Products

What will AGI do for Benzydamine?

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H23N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4O21U048EF, chemically known as 1-propanamine, n,n-dimethyl-3-((1-(phenylmethyl)-1h-indazol-3-yl)oxy)- but generally known as benzydamine, which bears US NIH Compound Identifier 12555. Benzydamine most often comes in base, hydrochloride, n-oxide, and salicylate forms. European Medicines Agency schedules Benzydamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05770MIG. The term BENZYDAMINE is an International Non-Proprietary Name. World Health Organization schedules benzydamine in its Anatomical Therapeutic Chemical (ATC) Classification. BENZYDAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benzydamine under HS 29339990 and SITC 51577. As of Q4 2014, BENZYDAMINE remains the US FDA Preferred Term for this commodity. Benzydamine bears US NLM identifiers UMLS ID C0005099 and NCI Concept Code C83548. SMILES: O(C1NN(C2C1CCCC2)CC1CCCCC1)CCCN(C)C.